Evolent Health Analyst Price Targets

Evolent Health Inc

EVHNYSE

$4.60

0.010.22%

In chiusura: Aug 28, 5:00 PM EST

$4.58

-0.02-0.43%

Post-mercato: Aug 28, 4:59 PM EST

Wall Street analyst price targets and consensus rating for Evolent Health (EVH).

Price Target Range — 12 Quarters

Analyst Consensus — 16 Analysts

3S.Buy

11Buy

2Hold

Consensus RatingBuy# Analysts16Avg. Consensus PT$11Upside to Avg. PT+133.6%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 18, 2026	JP Morgan	John Stansel	PT Raise	Overweight	$5→$6
Aug 17, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$5→$6
Aug 12, 2026	Truist Securities	Jailendra Singh	PT Cut	Hold	$7→$6
Aug 11, 2026	Citigroup	Daniel Grosslight	Upgrade	Neutral→Buy	$7→$6
Aug 10, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$7→$6
Jul 28, 2026	TD Cowen	Charles Rhyee	PT Cut	Buy	$8→$5
Jul 23, 2026	Citigroup	Daniel Grosslight	Downgrade	Buy→Neutral	$6→$7
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$6→$7
Jun 30, 2026	Truist Securities	Jailendra Singh	Downgrade	Buy→Hold	$7
Jun 12, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$6→$7
May 15, 2026	Citigroup	Daniel Grosslight	PT Raise	Buy	$4→$6
May 12, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$4→$6
May 7, 2026	Needham	Matthew Shea	PT Raise	Buy	$4→$5
Mar 2, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$12→$6
Feb 26, 2026	Citigroup	Daniel Grosslight	PT Cut	Buy	$6→$4
Feb 26, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$10→$5
Feb 26, 2026	Truist Securities	Jailendra Singh	PT Cut	Buy	$10→$6
Feb 25, 2026	Needham	Matthew Shea	PT Cut	Buy	$15→$4
Feb 25, 2026	RBC Capital	Ryan Halsted	PT Cut	Sector Perform	$5→$3
Feb 25, 2026	Keybanc	Matthew Gillmor	Downgrade	Overweight→Sector Weight	—